| Literature DB >> 33855352 |
Elena Bonora1, Sanjiban Chakrabarty2, Georgios Kellaris3, Makiko Tsutsumi4, Francesca Bianco1, Christian Bergamini5, Farid Ullah3, Federica Isidori1, Irene Liparulo5, Chiara Diquigiovanni1, Luca Masin5, Nicola Rizzardi5, Mariapia Giuditta Cratere1,6, Elisa Boschetti1, Valentina Papa7, Alessandra Maresca8, Giovanna Cenacchi7, Rita Casadio9, Pierluigi Martelli9, Ivana Matera10, Isabella Ceccherini10, Romana Fato5, Giuseppe Raiola11, Serena Arrigo10, Sara Signa10, Angela Rita Sementa10, Mariasavina Severino10, Pasquale Striano10, Chiara Fiorillo10, Tsuyoshi Goto12, Shumpei Uchino13,14, Yoshinobu Oyazato15, Hisayoshi Nakamura16, Sushil K Mishra17, Yu-Sheng Yeh12, Takema Kato4, Kandai Nozu18, Jantima Tanboon16, Ichiro Morioka19, Ichizo Nishino16, Tatsushi Toda20, Yu-Ichi Goto21, Akira Ohtake22, Kenjiro Kosaki23, Yoshiki Yamaguchi24, Ikuya Nonaka16, Kazumoto Iijima18, Masakazu Mimaki13, Hiroki Kurahashi4, Anja Raams2, Alyson MacInnes25, Mariel Alders26, Marc Engelen27, Gabor Linthorst25, Tom de Koning28, Wilfred den Dunnen29, Gerard Dijkstra30, Karin van Spaendonck26, Dik C van Gent2, Eleonora M Aronica31, Paolo Picco10, Valerio Carelli7,8, Marco Seri1, Nicholas Katsanis3, Floor A M Duijkers26, Mariko Taniguchi-Ikeda4,18,32, Roberto De Giorgio33.
Abstract
Abnormal gut motility is a feature of several mitochondrial encephalomyopathies, and mutations in genes such as TYMP and POLG, have been linked to these rare diseases. The human genome encodes three DNA ligases, of which only one, ligase III (LIG3), has a mitochondrial splice variant and is crucial for mitochondrial health. We investigated the effect of reduced LIG3 activity and resulting mitochondrial dysfunction in seven patients from three independent families, who showed the common occurrence of gut dysmotility and neurological manifestations reminiscent of mitochondrial neurogastrointestinal encephalomyopathy. DNA from these patients was subjected to whole exome sequencing. In all patients, compound heterozygous variants in a new disease gene, LIG3, were identified. All variants were predicted to have a damaging effect on the protein. The LIG3 gene encodes the only mitochondrial DNA (mtDNA) ligase and therefore plays a pivotal role in mtDNA repair and replication. In vitro assays in patient-derived cells showed a decrease in LIG3 protein levels and ligase activity. We demonstrated that the LIG3 gene defects affect mtDNA maintenance, leading to mtDNA depletion without the accumulation of multiple deletions as observed in other mitochondrial disorders. This mitochondrial dysfunction is likely to cause the phenotypes observed in these patients. The most prominent and consistent clinical signs were severe gut dysmotility and neurological abnormalities, including leukoencephalopathy, epilepsy, migraine, stroke-like episodes, and neurogenic bladder. A decrease in the number of myenteric neurons, and increased fibrosis and elastin levels were the most prominent changes in the gut. Cytochrome c oxidase (COX) deficient fibres in skeletal muscle were also observed. Disruption of lig3 in zebrafish reproduced the brain alterations and impaired gut transit in vivo. In conclusion, we identified variants in the LIG3 gene that result in a mitochondrial disease characterized by predominant gut dysmotility, encephalopathy, and neuromuscular abnormalities. Bonora et al. identify a new mitochondrial recessive disorder caused by biallelic variants in the LIG3 gene encoding DNA ligase III, which is responsible for mitochondrial DNA repair. Clinical signs include gut dysmotility and neurological features such as leucoencephalopathy, epilepsy and stroke-like episodes.Entities:
Keywords: zzm321990 LIG3zzm321990 ; CIPO; MNGIE; mtDNA repair; mtDNA replication
Year: 2021 PMID: 33855352 DOI: 10.1093/brain/awab056
Source DB: PubMed Journal: Brain ISSN: 0006-8950 Impact factor: 13.501